# Softimize

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/softimize

- Industry: Internet
- Headquarters: Petah Tikva, Israel
- Website: www.biot-med.com
- Total disclosed funding: $6.5M
- Latest round: Seed (Jun 29, 2021)
- Investors on record: 3

## About

Softimize Ltd. develops advanced infrastructure solutions for secure medical device cloud services, enhancing integrations to support diverse healthcare applications, including monitoring and diagnostics.Founded in 2016 in Petah Tikva, Israel, Softimize Ltd. provides medical device cloud solutions. The company has successfully completed one funding round, raising USD 6.5 mn in Seed funding on June 29, 2021, led by Bridges Israel and supported by North First Ventures and XT Hi-Tech. The founders include Boaz Vaizler, Daniel Adler, and Guy Vinograd, with Daniel Adler serving as the CEO.BioT is a leading provider of infrastructure solutions for medical device clouds, offering a comprehensive platform designed to facilitate the secure and compliant delivery of next-generation healthcare services. The company's core product includes a medical-grade architecture that ensures data security and compliance with global regulatory standards from inception. BioT's platform enables seamless integration with various cloud services, allowing medical devices to connect effortlessly and utilize ready-made services, which support a range of healthcare applications including monitoring, diagnostics, and therapeutic interventions. End-users of BioT’s services include healthcare providers such as clinics, hospitals, and home care settings, as well as device manufacturers across verticals like Cardiology, Neurology, and Dermatology. The company markets its solutions primarily in North America, Europe, and select regions in Asia, positioning its products to adapt to diverse healthcare needs and regulatory environments.BioT generates revenue through a subscription-based model, wherein clients—typically healthcare providers and medical device manufacturers—pay for access to the platform’s services, features, and regulatory compliance functionalities. The structure of transactions generally involves annual or monthly subscriptions, allowing for scalable usage based on the number of connected devices and services utilized. Clients can enhance their existing capabilities by integrating BioT’s platform with their current infrastructure, resulting in additional fees for customization and extended service offerings. Flagship products include modular cloud services and a developer studio that supports no-code, low-code, and custom coding options, facilitating rapid innovation and deployment of healthcare solutions. By fostering flexible partnerships and offering comprehensive cloud services, BioT ensures that its clients can maintain a competitive edge in a rapidly evolving healthcare landscape.In June 2021, Softimize Ltd. raised USD 6.5 mn in Seed funding to expand its team, expedite the next generation of its platform, and support its growing sales pipeline in the US and Europe. The company is focusing on launching additional products designed to enhance its platform's capabilities and expanding its market reach in North America and Europe by the end of 2023.

## Funding rounds

- Seed, Jun 29, 2021, $6.5M — North First Ventures, Bridges Israel, XT Hi-Tech

## Investors

- North First Ventures (https://capitalatlas.ai/funds/north-first-ventures) — Seed
- Bridges Israel (https://capitalatlas.ai/funds/bridges-israel) — Seed
- XT Hi-Tech (https://capitalatlas.ai/funds/xt-hi-tech) — Seed